B+
Bull case
25%
Probability
Target price
$48.00
+16.6% vs current
ACT
EnactBNasdaq / Financial Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$43.00
+4.5% vs current
B-
Bear case
25%
Probability
Target price
$35.00
-14.9% vs current
AI sentiment snapshot
Latest data as of 2026-04-15
Recent news sentiment (30D)
+18.4
Positive
Company
+23.6
Positive
Macro
+18.6
Positive
Pulse
-32.0
Negative
Sentiment proxy
+51.5
Score
AI commentary
Monitoring-style neutral. Primary-source evidence is solid, but the thesis is still mostly about preserving favorable credit and capital return rather than a new growth leg. Deterministic priors are neutral-to-slightly-negative, and the next real proof point is the May 6, 2026 earnings update rather than a clearly underappreciated catalyst today.
RankAlpha Sentiment Codex - 2026-04-15
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-06eventQ1 2026 earnings call on May 6 should test whether strong cure trends and elevated persistency are holdingMedium impact
Enact's IR events page lists the Q1 2026 earnings conference call for May 6, 2026. The key swing factors are whether NIW, persistency, delinquency formation, and reserve trends remain as favorable as the 4Q25 setup, when management highlighted a $60 million reserve release, a lower expected claim rate, and PMIERs sufficiency of about $1.9 billion at 162% [#8-K-2026-02-03] [#IR-2026-04-15].
2026-09-30catalystCapital return remains a meaningful support if excess capital and subsidiary dividends stay intactHigh impact
The 10-K says Enact typically returns capital through quarterly dividends and repurchases, declared a $0.21 first-quarter 2026 dividend, and disclosed a new $500 million repurchase authorization announced on February 3, 2026. It also noted EMICO paid about $610 million of dividends in 2025 supporting holding-company capital return capacity [#10-K-2026-02-27].
2026-09-30catalystCredit performance and PMIERs headroom are the core medium-term thesis lever, but they are still a monitoring itemMedium impact
Management's 4Q25 materials showed favorable cure performance, a lower expected claim rate on new and recent delinquencies, and PMIERs sufficiency of $1.919 billion at 162%. The 10-K also says updated PMIERs standards phase in through September 30, 2026 and the business remains tightly linked to GSE rules and alternative credit-risk transfer structures, so continued benign credit is supportive but not fully de-risked [#10-K-2026-02-27] [#8-K-2026-02-03].
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-15 • Updated nightlySource: Internal modelMethodology